1-[(3-Nitrophenyl)sulfonyl]piperidine-2-carboxylic acid, 95.0%, 500mg

5-Bromo-2-hydroxy-3-(trifluoromethyl)pyridine, 95.0%, 25g

(S)-(+)-1-(2-Chlorophenyl)-1,2-ethanediol, 95.0%, 10g

9-Bromoanthracene, 97.0%, 100g

1-(1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)piperidine-3-carboxylic acid, 95.0%, 1g

1-(2-Chloro-4-fluorophenyl)ethan-1-ol, 97.0%, 5g

N-Butylpropionamide>99.0%(GC)5g

9,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene, 98.0%, 25g

2,2-Difluoro-2-(4-chlorophenyl)acetic acid, 97.0%, 1g

Tubo de ensayo, 75 ml, 63 Pieza(s)

4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2h-pyrido[3,2-b][1,4]oxazine, 98%, 100mg

N-Acetyl-4-chloro-3,5-difluoroaniline, 95+%, 5g

N-(3-Nitrophenyl)acrylamide, 97%, 25g